Literature DB >> 25913564

Comment on: inhaled antimicrobial therapy--barriers to effective treatment, by J. Weers, inhaled antimicrobial therapy - barriers to effective treatment, Adv. Drug Deliv. Rev. (2015), http://dx.doi.org/10.1016/j.addr.2014.08.013.

David Cipolla1, Juergen Froehlich2, Igor Gonda2.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25913564     DOI： 10.1016/j.addr.2015.04.015

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN： 0169-409X            Impact factor:   15.470


× No keyword cloud information.
  2 in total

1.  How Much Surface Coating of Hydrophobic Azithromycin Is Sufficient to Prevent Moisture-Induced Decrease in Aerosolisation of Hygroscopic Amorphous Colistin Powder?

Authors:  Qi Tony Zhou; Zhi Hui Loh; Jiaqi Yu; Si-Ping Sun; Thomas Gengenbach; John A Denman; Jian Li; Hak-Kim Chan
Journal:  AAPS J       Date:  2016-06-02       Impact factor: 4.009

Review 2.  The Rationale and Evidence for Use of Inhaled Antibiotics to Control Pseudomonas aeruginosa Infection in Non-cystic Fibrosis Bronchiectasis.

Authors:  Rajiv Dhand
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2017-10-27       Impact factor: 2.849
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.